The University of California, Irvine has licensed a new cancer-fighting immunotherapy to biotech firm GlyTR Therapeutics Inc. for commercialization, paving the way for what researchers call a ...
A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...
Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...
One life was saved for every 456 men invited for a prostate cancer screening, the study found. View on euronews ...
While the benefits of screening tests for cervical cancer, breast cancer, and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback